These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 963188)

  • 1. An analysis of the effect of random and ageing mechanisms on the survival of platelets.
    Dassin E; Balitrand N; Najean Y
    Biomedicine; 1976 Feb; 25(1):23-5. PubMed ID: 963188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet production in idiopathic thrombocytopenic purpura.
    Najean Y; Rain JD; Dufour V
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):431-6. PubMed ID: 8414964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
    Peters AM; Saverymuttu SH; Wonke B; Lewis SM; Lavender JP
    Br J Haematol; 1984 Aug; 57(4):637-49. PubMed ID: 6430336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of platelets, megakaryocytes and their precursors: what to measure?
    Paulus JM; Deschamps JF; Prenant M; Casals FJ
    Blood Cells; 1980; 6(2):215-28. PubMed ID: 6991028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and in vivo redistribution of (111)Indium-labelled human platelets after intravenous protamine sulphate.
    Heyns AD; Lötter MG; Badenhorst PN; Kotze H; Killian FC; Herbst C; van Reenen OR; Minnaar PC
    Thromb Haemost; 1980 Oct; 44(2):65-8. PubMed ID: 7455993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and fate of (111)Indium-oxine labelled blood platelets in asplenic subjects.
    Heyns AD; Lötter MG; Badenhorst PN; van Reenen O; Pieters H; Minnaar PC
    Thromb Haemost; 1980 Oct; 44(2):100-4. PubMed ID: 6779398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy and extravascular platelet destruction in thrombotic thrombocytopenic purpura.
    Rosove MH; Bhuta S
    Arch Intern Med; 1985 May; 145(5):937-9. PubMed ID: 4039556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estimation of blood platelet survival. VI. Evaluation of the graphical method.
    Bolling DR; Murphy EA
    Johns Hopkins Med J; 1978 Aug; 143(2):25-31. PubMed ID: 682396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dietary cholesterol on platelet survival in the rabbit--a study using 14C-serotonin and 51chromium double-labelled platelets.
    Wanless IR
    Thromb Haemost; 1984 Aug; 52(1):85-9. PubMed ID: 6495269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Unresponsiveness to platelets. A case study.
    Pegels JG; Bruynes EC; Korthals Altes HR; Engelfriet CP; von dem Borne AE
    Vox Sang; 1982; 42(4):211-6. PubMed ID: 7046248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the lifespan of platelets labelled with 111In oxinate--first results.
    Todorović-Tirnanić M; Rolović Z; Obradović V; Bosnjaković V
    Med Pregl; 1993; 46 Suppl 1():97-9. PubMed ID: 8569625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111-labelled human platelets: a method for use in severe thrombocytopenia.
    Heyns Adu P; Badenhorst PN; Wessels P; Pieters H; Kotzè HF; Lötter MG
    Thromb Haemost; 1984 Dec; 52(3):226-9. PubMed ID: 6531748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
    Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
    Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mathematic models to assess platelet kinetics.
    Lötter MG; Heyns AD; Badenhorst PN; Wessels P; Martin van Zyl J; Kotze HF; Minnaar PC
    J Nucl Med; 1986 Jul; 27(7):1192-201. PubMed ID: 3088224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The young platelet population in children with cyanotic congenital heart disease.
    Goldschmidt B; Sorland SJ
    Thromb Haemost; 1976 Apr; 35(2):342-9. PubMed ID: 989634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities.
    Milton JG; Hutton RA; Tuddenham EG; Frojmovic MM
    J Lab Clin Med; 1985 Sep; 106(3):326-35. PubMed ID: 4031633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.